☆ 4.4 Letter

Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial

HAEMATOLOGICA (2015)

Get Full Text
Add to Collection

Journal

HAEMATOLOGICA
Volume 100, Issue 2, Pages E56-E59

Publisher

FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2014.110890

Keywords

multiple myeloma; elderly; relapse; bendamustine

Categories

Hematology

Funding

  1. NCI NIH HHS [P01 CA155258] Funding Source: Medline
  2. NATIONAL CANCER INSTITUTE [P01CA155258] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.